Steven C Quay - Net Worth and Insider Trading
Steven C Quay Net Worth
The estimated net worth of Steven C Quay is at least $41,028 dollars as of 2024-04-30. Steven C Quay is the President & CEO, 10% Owner of Atossa Therapeutics Inc and owns about 26,816 shares of Atossa Therapeutics Inc (ATOS) stock worth over $41,028. Details can be seen in Steven C Quay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven C Quay has not made any transactions after 2016-03-09 and currently still holds the listed stock(s).
Transaction Summary of Steven C Quay
Steven C Quay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven C Quay owns 2 companies in total, including Atossa Therapeutics Inc (ATOS) , and Adhera Therapeutics Inc (ATRX) .
Click here to see the complete history of Steven C Quay’s form 4 insider trades.
Insider Ownership Summary of Steven C Quay
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATOS | Atossa Therapeutics Inc | 2016-03-09 | director & 10 percent owner & CEO |
ATRX | Adhera Therapeutics Inc | 2003-09-11 | President & CEO and Chairman |
Steven C Quay Latest Holdings Summary
Steven C Quay currently owns a total of 1 stock. Steven C Quay owns 26,816 shares of Atossa Therapeutics Inc (ATOS) as of March 9, 2016, with a value of $41,028.
Latest Holdings of Steven C Quay
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATOS | Atossa Therapeutics Inc | 2016-03-09 | 26,816 | 1.53 | 41,028 |
Holding Weightings of Steven C Quay
Steven C Quay Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven C Quay has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 83 shares on March 9, 2016, which cost Steven C Quay around $5,550.
Insider Trading History of Steven C Quay
- 1
Steven C Quay Trading Performance
GuruFocus tracks the stock performance after each of Steven C Quay's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven C Quay is -5.45%. GuruFocus also compares Steven C Quay's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven C Quay within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven C Quay's insider trading performs compared to the benchmark.
Performance of Steven C Quay
Average Return
-68.42%
Outperforming Transactions
0%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 41.06 | -5.45 | -26.03 | -68.42 | -68.42 | -71.2 |
Relative Return to S&P 500(%) | 37.12 | -14.47 | -38.32 | -89.38 | -88.61 | -83.62 |
Steven C Quay Ownership Network
Ownership Network List of Steven C Quay
Ownership Network Relation of Steven C Quay
Steven C Quay Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Steven C Quay is the director & 10 percent owner & CEO of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Steven C Quay made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Steven C Quay Mailing Address
Above is the net worth, insider trading, and ownership report for Steven C Quay. You might contact Steven C Quay via mailing address: 22026 20th Avenue S E, Suite 102, Bothell Wa 98021.